- Report
- May 2024
- 186 Pages
Global
From €3256EUR$3,374USD£2,750GBP
€3618EUR$3,749USD£3,056GBP
- Report
- March 2024
- 199 Pages
Global
From €3256EUR$3,374USD£2,750GBP
€3618EUR$3,749USD£3,056GBP
- Report
- January 2024
- 150 Pages
Global
From €5742EUR$5,950USD£4,850GBP
- Report
- February 2024
- 175 Pages
Global
From €4825EUR$5,000USD£4,076GBP
- Report
- April 2024
- 194 Pages
Global
From €4777EUR$4,950USD£4,035GBP
- Report
- April 2024
- 152 Pages
Global
From €3812EUR$3,950USD£3,220GBP
- Clinical Trials
- June 2024
- 240 Pages
Global
From €2895EUR$3,000USD£2,445GBP
- Report
- May 2024
- 182 Pages
Global
From €4729EUR$4,900USD£3,994GBP
- Report
- October 2023
- 150 Pages
Global
From €2412EUR$2,499USD£2,037GBP
- Report
- April 2024
- 115 Pages
Global
From €4343EUR$4,500USD£3,668GBP
- Report
- October 2023
- 190 Pages
Global
From €4729EUR$4,900USD£3,994GBP
- Report
- February 2024
- 175 Pages
Global
From €4825EUR$5,000USD£4,076GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1930EUR$2,000USD£1,630GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1930EUR$2,000USD£1,630GBP
- Report
- February 2024
- 110 Pages
Global
From €4584EUR$4,750USD£3,872GBP
- Report
- March 2024
- 200 Pages
Global
From €4005EUR$4,150USD£3,383GBP
- Report
- June 2022
- 95 Pages
Global
From €3812EUR$3,950USD£3,220GBP
- Report
- January 2022
- 200 Pages
Global
From €7238EUR$7,500USD£6,113GBP
- Report
- April 2022
- 191 Pages
Global
From €3074EUR$3,185USD£2,596GBP
€4391EUR$4,550USD£3,709GBP
- Report
- June 2023
- 200 Pages
Global
From €7238EUR$7,500USD£6,113GBP
![Loading Indicator](//www.researchandmarkets.com/images/loading.gif)
The Asthma Treatment market is composed of a variety of drugs used to treat asthma symptoms. These drugs are divided into two main categories: long-term control medications and quick-relief medications. Long-term control medications are taken daily to reduce inflammation and prevent asthma symptoms. Quick-relief medications are taken as needed to quickly relieve asthma symptoms. Common long-term control medications include inhaled corticosteroids, leukotriene modifiers, and long-acting beta-agonists. Common quick-relief medications include short-acting beta-agonists and anticholinergics.
The Asthma Treatment market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include GlaxoSmithKline, Merck & Co., Novartis, Sanofi, and Teva Pharmaceuticals. Show Less Read more